中国心血管病预防指南(2017)

2018-01-30 中华心血管病杂志编辑委员会 中华心血管病杂志,2018,46(1) :10-25.

2011年,中华医学会心血管病学分会及中华心血管病杂志编辑委员会组织发表了《中国心血管病预防指南》,在积极应对心血管病带来的严峻挑战,指导我国临床心血管病的预防工作方面发挥了重要的作用。 近年来,我国心血管病患病率仍处于持续上升阶段,心血管病死亡率仍居首位,高于肿瘤及其他疾病,大约每5例死亡中就有2例死于心血管病。心血管病死亡率、发病率及患病率持续增长,已经给我国带来了沉重的社会及经济负担

中文标题:

中国心血管病预防指南(2017)

发布日期:

2018-01-30

简要介绍:

2011年,中华医学会心血管病学分会及中华心血管病杂志编辑委员会组织发表了《中国心血管病预防指南》,在积极应对心血管病带来的严峻挑战,指导我国临床心血管病的预防工作方面发挥了重要的作用。

近年来,我国心血管病患病率仍处于持续上升阶段,心血管病死亡率仍居首位,高于肿瘤及其他疾病,大约每5例死亡中就有2例死于心血管病。心血管病死亡率、发病率及患病率持续增长,已经给我国带来了沉重的社会及经济负担。与此同时,面对心血管病高发的严峻形势,国内外心血管病预防工作也取得了许多进展。为此,我们参考国内外最新临床研究证据,吸取国内外最新相关指南,在2011年《中国心血管病预防指南》的基础上更新了内容,发表为《中国心血管病预防指南(2017)》,以便更好地指导我国临床心血管病的预防工作。

 

拓展指南:心血管相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国心血管病预防指南(2017))] GetToolGuiderByIdResponse(projectId=1, id=ef8261c001553a4d, title=中国心血管病预防指南(2017), enTitle=, guiderFrom=中华心血管病杂志,2018,46(1) :10-25., authorId=null, author=, summary=2011年,中华医学会心血管病学分会及中华心血管病杂志编辑委员会组织发表了《中国心血管病预防指南》,在积极应对心血管病带来的严峻挑战,指导我国临床心血管病的预防工作方面发挥了重要的作用。 近年来,我国心血管病患病率仍处于持续上升阶段,心血管病死亡率仍居首位,高于肿瘤及其他疾病,大约每5例死亡中就有2例死于心血管病。心血管病死亡率、发病率及患病率持续增长,已经给我国带来了沉重的社会及经济负担, cover=, journalId=null, articlesId=null, associationId=390, associationName=中华心血管病杂志编辑委员会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Jan 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2011年,中华医学会心血管病学分会及中华心血管病杂志编辑委员会组织发表了《中国心血管病预防指南》,在积极应对心血管病带来的严峻挑战,指导我国临床心血管病的预防工作方面发挥了重要的作用。 <BR><BR>近年来,我国心血管病患病率仍处于持续上升阶段,心血管病死亡率仍居首位,高于肿瘤及其他疾病,大约每5例死亡中就有2例死于心血管病。心血管病死亡率、发病率及患病率持续增长,已经给我国带来了沉重的社会及经济负担。与此同时,面对心血管病高发的严峻形势,国内外心血管病预防工作也取得了许多进展。为此,我们参考国内外最新临床研究证据,吸取国内外最新相关指南,在2011年《中国心血管病预防指南》的基础上更新了内容,发表为《中国心血管病预防指南(2017)》,以便更好地指导我国临床心血管病的预防工作。</P> <P> </P>拓展指南:<strong>与<font color=red>心血管</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=e66fa1c0015520af" title="2018 AHA科学声明:心血管疾病和乳腺癌" target=_blank>2018 AHA科学声明:心血管疾病和乳腺癌</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=df94e1c001538547" title="美国心律学会和美国麻醉医师学会关于心血管植入型电子器械患者围术期处理专家共识解读" target=_blank>美国心律学会和美国麻醉医师学会关于心血管植入型电子器械患者围术期处理专家共识解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b8f8a1c00153507b" title="2017 AHA科学声明:儿童和青少年时期遭遇不幸和心血管代谢结局" target=_blank>2017 AHA科学声明:儿童和青少年时期遭遇不幸和心血管代谢结局</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9dbb51c00152891c" title="2017国际复苏联合会共识:心肺复苏和心血管急救治疗推荐要点" target=_blank>2017国际复苏联合会共识:心肺复苏和心血管急救治疗推荐要点</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=542a21c001519309" title="2017 ILCOR国际共识:心肺复苏和心血管急救治疗推荐-概要" target=_blank>2017 ILCOR国际共识:心肺复苏和心血管急救治疗推荐-概要</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%A1%80%E7%AE%A1" target=_blank>有关心血管更多指南</a></ul>, tagList=[TagDto(tagId=62122, tagName=心血管病预防)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9788, appHits=929, showAppHits=2, pcHits=7679, showPcHits=1777, likes=135, shares=59, comments=5, approvalStatus=1, publishedTime=Fri Feb 09 21:14:01 CST 2018, publishedTimeString=2018-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Feb 09 21:14:01 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 14:41:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国心血管病预防指南(2017))])
中国心血管病预防指南(2017)
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=303471, encodeId=5e9e3034e1ea, content=很及时.有我们中国自己的循证依据, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Sat Apr 07 07:32:22 CST 2018, time=2018-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286650, encodeId=c7622866509b, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 10 01:59:48 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286612, encodeId=e722286612a1, content=考拉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Fri Feb 09 22:24:07 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286595, encodeId=5aa228659521, content=不确定性太多.需要努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Feb 09 21:49:30 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286593, encodeId=2bb62865933d, content=学习了.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Fri Feb 09 21:48:06 CST 2018, time=2018-02-09, status=1, ipAttribution=)]
    2018-04-07 1dea4a7em68(暂无匿称)

    很及时.有我们中国自己的循证依据

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=303471, encodeId=5e9e3034e1ea, content=很及时.有我们中国自己的循证依据, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Sat Apr 07 07:32:22 CST 2018, time=2018-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286650, encodeId=c7622866509b, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 10 01:59:48 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286612, encodeId=e722286612a1, content=考拉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Fri Feb 09 22:24:07 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286595, encodeId=5aa228659521, content=不确定性太多.需要努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Feb 09 21:49:30 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286593, encodeId=2bb62865933d, content=学习了.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Fri Feb 09 21:48:06 CST 2018, time=2018-02-09, status=1, ipAttribution=)]
    2018-02-10 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=303471, encodeId=5e9e3034e1ea, content=很及时.有我们中国自己的循证依据, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Sat Apr 07 07:32:22 CST 2018, time=2018-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286650, encodeId=c7622866509b, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 10 01:59:48 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286612, encodeId=e722286612a1, content=考拉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Fri Feb 09 22:24:07 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286595, encodeId=5aa228659521, content=不确定性太多.需要努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Feb 09 21:49:30 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286593, encodeId=2bb62865933d, content=学习了.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Fri Feb 09 21:48:06 CST 2018, time=2018-02-09, status=1, ipAttribution=)]
    2018-02-09 orangesking

    考拉

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=303471, encodeId=5e9e3034e1ea, content=很及时.有我们中国自己的循证依据, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Sat Apr 07 07:32:22 CST 2018, time=2018-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286650, encodeId=c7622866509b, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 10 01:59:48 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286612, encodeId=e722286612a1, content=考拉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Fri Feb 09 22:24:07 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286595, encodeId=5aa228659521, content=不确定性太多.需要努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Feb 09 21:49:30 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286593, encodeId=2bb62865933d, content=学习了.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Fri Feb 09 21:48:06 CST 2018, time=2018-02-09, status=1, ipAttribution=)]
    2018-02-09 虈亣靌

    不确定性太多.需要努力学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=303471, encodeId=5e9e3034e1ea, content=很及时.有我们中国自己的循证依据, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Sat Apr 07 07:32:22 CST 2018, time=2018-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286650, encodeId=c7622866509b, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Feb 10 01:59:48 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286612, encodeId=e722286612a1, content=考拉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Fri Feb 09 22:24:07 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286595, encodeId=5aa228659521, content=不确定性太多.需要努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Feb 09 21:49:30 CST 2018, time=2018-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286593, encodeId=2bb62865933d, content=学习了.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Fri Feb 09 21:48:06 CST 2018, time=2018-02-09, status=1, ipAttribution=)]
    2018-02-09 1e0f8808m18(暂无匿称)

    学习了.谢谢分享.

    0